100 related articles for article (PubMed ID: 25583799)
1. Turning telomerase into a Jekyll and Hyde case?
Wellinger RJ
Cancer Discov; 2015 Jan; 5(1):19-21. PubMed ID: 25583799
[TBL] [Abstract][Full Text] [Related]
2. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
Mender I; Gryaznov S; Dikmen ZG; Wright WE; Shay JW
Cancer Discov; 2015 Jan; 5(1):82-95. PubMed ID: 25516420
[TBL] [Abstract][Full Text] [Related]
3. Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.
Mender I; Zhang A; Ren Z; Han C; Deng Y; Siteni S; Li H; Zhu J; Vemula A; Shay JW; Fu YX
Cancer Cell; 2020 Sep; 38(3):400-411.e6. PubMed ID: 32619407
[TBL] [Abstract][Full Text] [Related]
4. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
[TBL] [Abstract][Full Text] [Related]
5. Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Zhang G; Wu LW; Mender I; Barzily-Rokni M; Hammond MR; Ope O; Cheng C; Vasilopoulos T; Randell S; Sadek N; Beroard A; Xiao M; Tian T; Tan J; Saeed U; Sugarman E; Krepler C; Brafford P; Sproesser K; Murugan S; Somasundaram R; Garman B; Wubbenhorst B; Woo J; Yin X; Liu Q; Frederick DT; Miao B; Xu W; Karakousis GC; Xu X; Schuchter LM; Mitchell TC; Kwong LN; Amaravadi RK; Lu Y; Boland GM; Wei Z; Nathanson K; Herbig U; Mills GB; Flaherty KT; Herlyn M; Shay JW
Clin Cancer Res; 2018 Oct; 24(19):4771-4784. PubMed ID: 29563139
[No Abstract] [Full Text] [Related]
6.
Mender I; Batten K; Peyton M; Vemula A; Cornelius C; Girard L; Gao B; Minna JD; Shay JW
Cancer Res; 2020 Mar; 80(5):929-936. PubMed ID: 31948943
[TBL] [Abstract][Full Text] [Related]
7. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex.
Bianchi A; Shore D
Mol Cell; 2008 Jul; 31(2):153-65. PubMed ID: 18657499
[TBL] [Abstract][Full Text] [Related]
8. Oxidative guanine base damage regulates human telomerase activity.
Fouquerel E; Lormand J; Bose A; Lee HT; Kim GS; Li J; Sobol RW; Freudenthal BD; Myong S; Opresko PL
Nat Struct Mol Biol; 2016 Dec; 23(12):1092-1100. PubMed ID: 27820808
[TBL] [Abstract][Full Text] [Related]
9. Mammalian telomeres and telomerase: why they matter for cancer and aging.
Blasco MA
Eur J Cell Biol; 2003 Sep; 82(9):441-6. PubMed ID: 14582532
[TBL] [Abstract][Full Text] [Related]
10. A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer.
Eglenen-Polat B; Kowash RR; Huang HC; Siteni S; Zhu M; Chen K; Bender ME; Mender I; Stastny V; Drapkin BJ; Raj P; Minna JD; Xu L; Shay JW; Akbay EA
Nat Commun; 2024 Jan; 15(1):672. PubMed ID: 38253555
[TBL] [Abstract][Full Text] [Related]
11. Interaction of deoxyguanosine nucleotide analogs with human telomerase.
Tendian SW; Parker WB
Mol Pharmacol; 2000 Apr; 57(4):695-9. PubMed ID: 10727514
[TBL] [Abstract][Full Text] [Related]
12. Chromosome healing: spontaneous and programmed de novo telomere formation by telomerase.
Melek M; Shippen DE
Bioessays; 1996 Apr; 18(4):301-8. PubMed ID: 8967898
[TBL] [Abstract][Full Text] [Related]
13. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
14. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
15. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
[TBL] [Abstract][Full Text] [Related]
16. De novo telomere addition by Tetrahymena telomerase in vitro.
Wang H; Blackburn EH
EMBO J; 1997 Feb; 16(4):866-79. PubMed ID: 9049315
[TBL] [Abstract][Full Text] [Related]
17. Developmentally regulated initiation of DNA synthesis by telomerase: evidence for factor-assisted de novo telomere formation.
Bednenko J; Melek M; Greene EC; Shippen DE
EMBO J; 1997 May; 16(9):2507-18. PubMed ID: 9171363
[TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase.
Chan SR; Blackburn EH
Philos Trans R Soc Lond B Biol Sci; 2004 Jan; 359(1441):109-21. PubMed ID: 15065663
[TBL] [Abstract][Full Text] [Related]
19. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
20. [Telomeres, telomerase and development of cancer].
Andersen TI
Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
